Guest guest Posted March 21, 2005 Report Share Posted March 21, 2005 http://www.businessweek.com/ap/financialnews/D88VCQIO0.htm? campaign_id=apn_tech_down Prescription skin medication maker Medicis Pharmaceutical Corp. said it agreed to purchase Inamed Corp., a maker of breast implants and obesity treatments, for about $75 per share in cash and stock, for a total equity value of $2.8 billion. NYSE-listed shares of Medicis were down 59 cents, or 1.8 percent, at $31.68 in premarket activity. ~~~~~~~~ www.BreastImplantAwareness.org Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.